JP2024526820A5 - - Google Patents
Info
- Publication number
- JP2024526820A5 JP2024526820A5 JP2024502611A JP2024502611A JP2024526820A5 JP 2024526820 A5 JP2024526820 A5 JP 2024526820A5 JP 2024502611 A JP2024502611 A JP 2024502611A JP 2024502611 A JP2024502611 A JP 2024502611A JP 2024526820 A5 JP2024526820 A5 JP 2024526820A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163223265P | 2021-07-19 | 2021-07-19 | |
| US63/223,265 | 2021-07-19 | ||
| PCT/US2022/037479 WO2023003815A1 (en) | 2021-07-19 | 2022-07-18 | Actrii proteins and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024526820A JP2024526820A (ja) | 2024-07-19 |
| JP2024526820A5 true JP2024526820A5 (https=) | 2025-07-17 |
| JPWO2023003815A5 JPWO2023003815A5 (https=) | 2025-07-17 |
Family
ID=84979535
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024502611A Pending JP2024526820A (ja) | 2021-07-19 | 2022-07-18 | Ａｃｔｒｉｉタンパク質およびその用途 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20240327494A1 (https=) |
| EP (1) | EP4373577A4 (https=) |
| JP (1) | JP2024526820A (https=) |
| KR (1) | KR20240049857A (https=) |
| CN (1) | CN117957014A (https=) |
| AU (1) | AU2022316103A1 (https=) |
| CA (1) | CA3225613A1 (https=) |
| CL (1) | CL2024000151A1 (https=) |
| CO (1) | CO2024001551A2 (https=) |
| CR (1) | CR20240061A (https=) |
| DO (1) | DOP2024000016A (https=) |
| EC (1) | ECSP24012819A (https=) |
| GE (1) | GEAP202416461A (https=) |
| IL (1) | IL310141A (https=) |
| JO (1) | JOP20240010A1 (https=) |
| MX (1) | MX2024000829A (https=) |
| PE (1) | PE20240777A1 (https=) |
| WO (1) | WO2023003815A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021189010A1 (en) | 2020-03-20 | 2021-09-23 | Keros Therapeutics, Inc. | Methods of using activin receptor type iib variants |
| IL296394A (en) | 2020-03-20 | 2022-11-01 | Keros Therapeutics Inc | Type ii activin receptor chimeras and methods of using them |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20180055822A1 (en) * | 2015-03-13 | 2018-03-01 | Repoceuticals Aps | Melatonin for Preventing and Treating Radiation Cystitis |
| CA3005975A1 (en) * | 2015-11-23 | 2017-06-01 | Acceleron Pharma Inc. | Methods for treating eye disorders |
| HRP20210694T1 (hr) * | 2016-07-15 | 2021-09-17 | Acceleron Pharma, Inc. | Pripravci koji sadrže actriia polipeptide za uporabu za liječenje plućne hipertenzije |
-
2022
- 2022-07-18 GE GEAP202416461A patent/GEAP202416461A/en unknown
- 2022-07-18 AU AU2022316103A patent/AU2022316103A1/en active Pending
- 2022-07-18 KR KR1020247005282A patent/KR20240049857A/ko active Pending
- 2022-07-18 CR CR20240061A patent/CR20240061A/es unknown
- 2022-07-18 IL IL310141A patent/IL310141A/en unknown
- 2022-07-18 MX MX2024000829A patent/MX2024000829A/es unknown
- 2022-07-18 CA CA3225613A patent/CA3225613A1/en active Pending
- 2022-07-18 CN CN202280060109.7A patent/CN117957014A/zh active Pending
- 2022-07-18 US US18/580,425 patent/US20240327494A1/en active Pending
- 2022-07-18 JP JP2024502611A patent/JP2024526820A/ja active Pending
- 2022-07-18 EP EP22846466.5A patent/EP4373577A4/en active Pending
- 2022-07-18 PE PE2024000111A patent/PE20240777A1/es unknown
- 2022-07-18 WO PCT/US2022/037479 patent/WO2023003815A1/en not_active Ceased
-
2024
- 2024-01-17 CL CL2024000151A patent/CL2024000151A1/es unknown
- 2024-01-18 JO JOJO/P/2024/0010A patent/JOP20240010A1/ar unknown
- 2024-01-18 DO DO2024000016A patent/DOP2024000016A/es unknown
- 2024-02-14 CO CONC2024/0001551A patent/CO2024001551A2/es unknown
- 2024-02-19 EC ECSENADI202412819A patent/ECSP24012819A/es unknown